Modulation by cholecystokinins of 3H‐spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites
- 8 December 1981
- journal article
- Published by Wiley in Acta Physiologica Scandinavica
- Vol. 113 (4) , 567-569
- https://doi.org/10.1111/j.1748-1716.1981.tb06942.x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Influence of cholecystokinin octapeptide sulfate ester on brain monoamine metabolism in ratsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
- The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassayBrain Research, 1981
- Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptidesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
- Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in miceEuropean Journal of Pharmacology, 1981
- A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracingNeuroscience, 1980
- Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injectionEuropean Journal of Pharmacology, 1980
- Cholecystokinin Receptors in the Brain: Characterization and DistributionScience, 1980
- Multiple receptors for dopamineNature, 1979
- 3H-spiroperidol labels dopamine receptors in pituitary and brainEuropean Journal of Pharmacology, 1977
- Immunochemical evidence of cholecystokinin-like peptides in brainNature, 1976